Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States ☆

INTRODUCTION: In the United States, routine human papillomavirus (HPV) vaccination is recommended for females and males at age 11 or 12 years; the series can be started at age 9 years. Vaccination is also recommended for females through age 26 years and males through age 21 years. The objective of t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Vaccine
Huvudupphovsmän: Chesson, Harrell W., Meites, Elissa, Ekwueme, Donatus U., Saraiya, Mona, Markowitz, Lauri E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745692/
https://ncbi.nlm.nih.gov/pubmed/29887325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2018.04.071
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk